stars 1 stars 2 stars 3

On September 5, 2017 Bio-Techne proudly announced its acquisition of Trevigen, Inc. For over 25 years, Trevigen has developed innovative tools for generating and analyzing physiologic cell culture models, such as organoids, tumorspheres, and stem cell-derived cellular systems. These models are being used to make critical advancements in drug discovery, toxicology, regenerative medicine, cell therapy, and cancer research. With strong brands like the CultrexTM Basement Membrane Matrix and the CometAssayTM for cell damage, the Trevigen product portfolio is an important addition to Bio-Techne. It solidifies our ability to offer full workflow solutions to customers using 2D and 3D culture models to investigate cell behavior and cytotoxic events.

Trevigen, Inc. Questions

The Trevigen, Inc. annual revenue was $1.2 billion in 2026.

3 people are employed at Trevigen, Inc..

Trevigen, Inc. is based in Gaithersburg, Maryland.

The NAICS codes for Trevigen, Inc. are [54, 541714, 5417, 54171, 541].

The SIC codes for Trevigen, Inc. are [87, 873].

Top Trevigen, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users